About: Economic analysis of healthcare-associated infection prevention and control interventions in medical and surgical units: Systematic review using a discounting approach

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Economic analysis of healthcare-associated infection prevention and control interventions in medical and surgical units: Systematic review using a discounting approach Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Economic analysis of healthcare-associated infection prevention and control interventions in medical and surgical units: Systematic review using a discounting approach
Creator	Baillot, Aurélie Beogo, Idrissa Boivin, Sandra Jabbour, Mira Kilpatrick, Kelley Parisien, Natasha Robins, Stephanie Sia, Drissa Séguin, Catherine Tchouaket Nguemeleu, Eric Nguemeleu, Eric Robins,
Source	Elsevier; Medline; PMC
abstract	BACKGROUND: Nosocomial or healthcare-associated infections (HCAIs) are associated with a financial burden that affects both patients and healthcare institutions worldwide. The clinical best care practices (CBPs) of hand hygiene, hygiene and sanitation, screening, and basic and additional precautions aim to reduce this burden. The COVID-19 pandemic has confirmed these four CBPs are critically important prevention practices that limit the spread of HCAIs. AIM: This paper conducted a systematic review of economic evaluations related to these four CBPs using a discounting approach. METHODS: We searched for articles published between 2000 and 2019. We included economic evaluations of infection prevention and control of Clostridioides difficile-associated diarrhoea, meticillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and carbapenem-resistant Gram-negative bacilli. Results were analyzed with: cost-minimization, cost-effectiveness, cost-utility, cost-benefit and cost-consequence analyses. Articles were assessed for quality. RESULTS: A total of 11 898 articles were screened and seven were included. Most studies (4/7) were of overall moderate quality. All studies demonstrated cost effectiveness of CBPs. The average yearly net cost savings from the CBPs ranged from $252 847 (2019 $CAD) to $1 691 823 depending on the rate of discount (3% and 8%). The average incremental benefit cost ratio of CBPs varied from 2.48 to 7.66. CONCLUSION: In order to make efficient use of resources and maximize health benefits, ongoing research in the economic evaluation of infection control should be carried out to support evidence-based healthcare policy decisions.
has issue date	2020-07-08(xsd:dateTime)
bibo:doi	10.1016/j.jhin.2020.07.004
bibo:pmid	32652215
has license	no-cc
sha1sum (hex)	2c9e454b32d8b75719fb80effc6e2655026a1362
schema:url	https://doi.org/10.1016/j.jhin.2020.07.004
resource representing a document's title	Economic analysis of healthcare-associated infection prevention and control interventions in medical and surgical units: Systematic review using a discounting approach
has PubMed Central identifier	PMC7341040
has PubMed identifier	32652215
schema:publication	J Hosp Infect
resource representing a document's body	covid:2c9e454b32d8b75719fb80effc6e2655026a1362#body_text
is schema:about of	named entity 'discounting' named entity 'Journal' named entity 'healthcare-associated' named entity 'healthcare-associated infection' named entity 'HCAI' named entity 'Economic analysis' named entity 'Economic analysis' named entity 'infection prevention and control' named entity 'prevention and control' named entity 'HCAI' named entity 'natural units' named entity 'hydrogen peroxide' named entity 'return on investment' named entity 'Research results' named entity 'audit' named entity 'Canadian' named entity 'systematic review' named entity 'prevention and control' named entity 'cost-effective' named entity 'GeneXpert' named entity 'MRSA' named entity 'HCAI' named entity 'exchange rate' named entity 'prevention and control' named entity 'COVID-19 pandemic' named entity 'spread of disease' named entity 'pathogens' named entity 'mupirocin' named entity 'infection prevention' named entity 'hygiene' named entity 'CAD' named entity 'mupirocin' named entity 'hand hygiene' named entity 'hand hygiene' named entity 'Hand hygiene' named entity 'Canadian dollars' named entity 'cross-sectional studies' named entity 'economic evaluation' named entity 'Care providers' named entity 'spreadsheet' named entity 'VRE' named entity 'contact tracing' named entity 'hand hygiene' named entity 'infection control' named entity 'economic evaluation' named entity 'MRSA' named entity 'hygiene' named entity 'pharmacoeconomic' named entity 'prevention and control' named entity 'assessment of cost' named entity 'CAD' named entity 'health outcomes' named entity 'systematic review' named entity 'research team' named entity 'quasi-experimental' named entity 'Chromogenic' named entity 'systematic review' named entity 'HCAI' named entity 'infection prevention' named entity 'prevention and control' named entity 'hand hygiene' named entity 'prevention and control' named entity 'GeneXpert' named entity 'quality assessment' named entity 'CAD' named entity 'cost benefit' named entity 'human resources' named entity 'cost-effectiveness' named entity 'economic evaluation' named entity 'grey literature'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software